Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,068
datasets available to search
ShareScore release 0.9.0
Dataset results
1,068 results for “PD-1”
Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC)
ClinicalTrials.gov study NCT05795244. IPD Sharing: NO. Countries: 1. Publications: 1.
PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT03427827. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma
ClinicalTrials.gov study NCT03852251. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04225364. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study
ClinicalTrials.gov study NCT07050940. IPD Sharing: NO. Countries: 1. Publications: 1.
Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03430479. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04379739. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy
ClinicalTrials.gov study NCT03616834. IPD Sharing: NO. Countries: 1. Publications: 1.
PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer
ClinicalTrials.gov study NCT04715633. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
ClinicalTrials.gov study NCT07068763. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT04518280. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Sol
ClinicalTrials.gov study NCT04348916. IPD Sharing: NO. Countries: 2. Publications: 1.
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
ClinicalTrials.gov study NCT04892381. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
ClinicalTrials.gov study NCT05615142. IPD Sharing: NO. Countries: 1. Publications: 7.
Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.
ClinicalTrials.gov study NCT07394387. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC
ClinicalTrials.gov study NCT04900363. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
ClinicalTrials.gov study NCT05671510. IPD Sharing: NO. Countries: 12. Publications: 2.
PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT06933251. IPD Sharing: NO. Countries: 1. Publications: 2.
Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05156788. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
ClinicalTrials.gov study NCT02758587. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.